Resolution of Severe Ischemia–Reperfusion Injury Post–Lung Transplantation After Administration of Endobronchial Surfactant
| Autor: | Peter Hopkins, F. Kermeen, J. McCarthy, Marc Ziegenfuss, D. Mullany, Keith McNeil, John F. Fraser, John Dunning |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine medicine.medical_specialty medicine.medical_treatment Ischemia Pulmonary compliance Hypoxemia Bronchoscopy medicine Extracorporeal membrane oxygenation Fiber Optic Technology Humans Lung transplantation Lung Optical Fibers Biological Products Transplantation business.industry Pulmonary Surfactants Middle Aged medicine.disease Surgery Instillation Drug medicine.anatomical_structure Reperfusion Injury Female Radiography Thoracic medicine.symptom Respiratory Insufficiency Cardiology and Cardiovascular Medicine business Reperfusion injury Follow-Up Studies Lung Transplantation |
| Zdroj: | The Journal of Heart and Lung Transplantation. 26:850-856 |
| ISSN: | 1053-2498 |
| DOI: | 10.1016/j.healun.2007.05.016 |
| Popis: | Background Ischemia–reperfusion injury (IRI) is a prominent cause of primary graft failure after lung transplantation and is associated with an altered surfactant profile. Experimental animal studies have found that replacement with exogenous surfactant administered via fiber-optic bronchoscopy (FOB) enhanced recovery from IRI with improved pulmonary compliance and gas exchange after lung transplantation. We report our clinical experience with FOB instillation of surfactant in severe IRI after human lung transplantation. Methods This study is a retrospective review of 106 consecutive lung or heart–lung transplants performed at a single institution. Severe IRI was defined as diffuse roentgenographic alveolar infiltrates, worsening hypoxemia and decreased lung compliance within 72 hours of lung transplantation. One vial of surfactant (20 mg/ml phospholipid) was instilled into each segmental bronchus upon diagnosis of IRI. Results Six patients (5 bilateral sequential and 1 re-do heart–lung transplant), mean age 46 years, were diagnosed with IRI and surfactant was administered at a mean of 37 hours (range 2.3 to 98) post-transplant. Mean graft ischemia time was 376 minutes (range 187 to 625) and cardiopulmonary bypass time 174 minutes (range 0 to 210). Mean Pao 2 [mm Hg]/Fio 2 ratio before and 48 hours after surfactant instillation was 70 and 223, respectively. Significant resolution of radiologic infiltrates was evident in all cases within 24 hours. Successful extubation occurred at a mean of 13.5 days and survival is presently 100% at 19 months (range 3 to 54). Conclusions Bronchoscopic instillation of surfactant improves oxygenation and prognosis after severe IRI in lung transplant recipients. It represents a cost-effective, relatively non-invasive therapeutic alternative to extracorporeal membrane oxygenation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|